6 completed, 1 withdrawn. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow presatovir: new trials by email Literature Review of presatovir trials Research Report on presatovir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection Presatovir, Placebo - Respiratory Syncytial Virus (RSV) | Phase 2 | Completed | Gilead Sciences | 61 | 2015-12-31 | 2018-11-28 |
| Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract Presatovir, Placebo - Respiratory Syncytial Virus Infection | Phase 2 | Completed | Gilead Sciences | 60 | 2015-01-31 | 2018-09-24 |
| Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract Presatovir, Placebo - Respiratory Syncytial Virus | Phase 2 | Completed | Gilead Sciences | 189 | 2015-01-23 | 2018-08-06 |
| Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection Presatovir, Presatovir placebo - Respiratory Syncytial Virus Infection | Phase 2 | Completed | Gilead Sciences | 189 | 2014-06-09 | 2018-09-24 |
| Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV) GS-5806, Placebo - Respiratory Syncytial Virus Infections | Phase 1 | Withdrawn | Gilead Sciences | 2013-05-01 | 2013-10-28 | |
| A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806 GS-5806 - RSV Infection | Phase 1 | Completed | Gilead Sciences | 8 | 2013-03-01 | 2013-06-10 |
| Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV) GS-5806, Placebo - Respiratory Syncytial Virus Infections | Phase 2 | Completed | Gilead Sciences | 140 | 2012-11-01 | 2015-08-21 |
Respiratory Syncytial Virus Infections (5) · Virus Diseases (2) · Infections (1) · Respiratory Tract Infections (1)
Gilead Sciences (7)
United States (5) · Australia (4) · France (4) · United Kingdom (4) · Netherlands (3) · South Korea (3) · Belgium (2) · Canada (2) · Germany (2) · Israel (2) · Sweden (2) · Switzerland (2) · Brazil (1) · Italy (1) · New Zealand (1)
Adeyi Adeyemi, MD (1) · Peter Sly, MD (1) · Seth Toback, M.D. (1)
PMID 25140957, PMID 31793991, PMID 31915807, PMID 36964084
2014 (3), 2015 (1)